Johannes Jacob Pieter Kastelein New Amsterdam Pharma CO N.V. (NAMS) insider trading activity
Shares Held (Direct Ownership)
99K
24.53%
3M change
191.12%
12M change
Total Value Held
N/A
Johannes Jacob Pieter Kastelein Transaction History
JJP
Johannes Jacob Pieter Kastelein
Chief Scientific Officer
Naarden, P7